✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals

Aristo Bio-Tech and Lifescience Ltd.

ARISTO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹90 Cr.
P/E
22.23

Aristo Bio-Tech and Lifescience Ltd.

  • Aristo Bio-Tech&Lis
  • Crop Life Science
  • Aimco Pesticide
FAQs on Aristo Bio-Tech and Lifescience Ltd. Shareprice

Aristo Bio-Tech&Lis has given better returns compared to its competitors.
Aristo Bio-Tech&Lis has grown at ~9.67% over the last 1yrs while peers have grown at a median rate of -18.0%

Yes, Aristo Bio-Tech&Lis is expensive.
Latest PE of Aristo Bio-Tech&Lis is 22.23, while 3 year average PE is 17.84.
Also latest EV/EBITDA of Aristo Bio-Tech&Lis is 8.85 while 3yr average is 7.47.

View FAQ's On Business
Growth Table
  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Aimco Pesticide
Balance Sheet
  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Aimco Pesticide
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Aimco Pesticide
Cash Flow
  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Aimco Pesticide
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Aimco Pesticide
Quarterly Results
  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Aimco Pesticide
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Aristo Bio-Tech and Lifescience Ltd. Financials

Balance sheet of Aristo Bio-Tech&Lis is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Aristo Bio-Tech&Lis is increasing.
Latest net debt of Aristo Bio-Tech&Lis is ₹19.63 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹19.6 Crs.

Yes, profit is increasing.
The profit of Aristo Bio-Tech&Lis is ₹4.06 Crs for Mar 2025, ₹3.9 Crs for Mar 2024 and ₹3.56 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aristo Bio-Tech&Lis latest dividend payout ratio is 8.38% and 3yr average dividend payout ratio is 6.72%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech